
Beta-Blockers: Ineffective & Risky After Heart Attack?
REBOOT trial reveals beta-blockers offer no benefit post-heart attack for those with preserved heart function, possibly increasing risks for women. Polypill reduces cardiovascular events.
REBOOT trial reveals beta-blockers offer no benefit post-heart attack for those with preserved heart function, possibly increasing risks for women. Polypill reduces cardiovascular events.
A 2025 survey reveals widespread misconceptions about hypertension symptoms & management, despite awareness of helpful practices. Early diagnosis & monitoring are crucial.